Advertisement

Advertisement

CRI-CIMT-EATI-AACR Immunotherapy Conference

solid tumors
immunotherapy

Bacterial Therapy Tolerable, Shows Early Activity in Patients With Advanced Solid Tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treat...

sarcoma
immunotherapy

Patient-Partnered Genomics Study Identifies Immunotherapy as a Potential Treatment for Angiosarcomas

Angiosarcoma of the head, face, neck, or scalp is a rare cancer associated with high rates of local recurrence, distant metastasis, and poor prognosis. Because angiosarcoma is so rare, it is difficult...

solid tumors
immunotherapy

Cancer Vaccine Shows Clinical Benefit in Phase I Study of Patients With HER2-Positive Cancers

A preclinical study showing that a vaccination with a recombinant adenovirus expressing a truncated ErbB-2 antigen can cure advanced established murine breast cancer as well as extensive established m...

Advertisement

Advertisement



;
Advertisement